Table 1 Analysis of Sleep Architecture in CFS and Controls, Measured on Night 2 and Adjusted for Medication Use
| Â | CFS | NF | Â |
|---|---|---|---|
| Â | n = 35 | n = 40 | Â |
| Â | Adjusted Mean* | Adjusted Mean* | P-Value** |
Total sleep time (min) | 400.3 | 407.9 | 0.52 |
Sleep period time (min) | 453.8 | 457.8 | 0.79 |
Latency to sleep onset (min) | 21.3 | 17.1 | 0.47 |
REM latency (min) | 98.4 | 106.8 | 0.40 |
Sleep efficiency (%) | 88.3 | 90.2 | 0.32 |
Wake after onset (min) | 53.8 | 44.0 | 0.69 |
Wake % Sleep Period | 11.7 | 9.8 | 0.72 |
# Arousals | 105.7 | 110.2 | 0.81 |
Arousal index | 15.9 | 16.3 | 0.82 |
Stage 1 (% TST) | 9.6 | 9.5 | 0.79 |
Stage 2 (% TST) | 48.2 | 50.8 | 0.28 |
Stage 3/4 (% TST) | 19.9 | 17.4 | 0.20 |
REM (% TST) | 22.3 | 23.3 | 0.98 |